Falling in love with eye researchPublished: Sunday, November 17, 2019 By: Scott Meacham Source: NewsOK
When Younghwa “Henry” Shin, Ph.D., a co-founder and CEO of Excitant Therapeutics, entered graduate school at the University of Oklahoma Health Sciences Center (OUHSC), his interest was neuroscience.
Then, during a year of rotation structured to give students a taste of different projects and specialties, he was assigned to Dr. Jian-Xing "Jay" Ma’s lab in physiology that was doing eye research.
“Life takes you to interesting places,” Dr. Shin told me. “I never imagined myself falling in love with eye research — but I did. By the end of graduate school, I wanted to engage more closely with bench-to-bedside for people with visual impairment.”
Dr. Shin’s post-doctoral fellowship at OUHSC laid the foundation for Excitant Therapeutics, the company he co-founded with Drs. Jay Ma and Adam Duerfeldt, to commercialize the technology licensed from OU. Excitant is developing therapeutic agents for ophthalmic diseases with a focus on diabetic retinopathy, diabetic macular edema and age-related macular degeneration.
Read the story on NewsOK.com.